Rosa Lamarca

4.0k total citations · 2 hit papers
57 papers, 2.8k citations indexed

About

Rosa Lamarca is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health. According to data from OpenAlex, Rosa Lamarca has authored 57 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 27 papers in Physiology and 8 papers in Health. Recurrent topics in Rosa Lamarca's work include Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (25 papers) and Respiratory and Cough-Related Research (16 papers). Rosa Lamarca is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers), Asthma and respiratory diseases (25 papers) and Respiratory and Cough-Related Research (16 papers). Rosa Lamarca collaborates with scholars based in Spain, United Kingdom and United States. Rosa Lamarca's co-authors include Jordi Alonso, Montse Ferrer, Luis Prieto, Helen K. Reddel, Peter J. Barnes, Eric D. Bateman, Paul M. O’Byrne, J. Mark FitzGerald, Christina Keen and Antònia Domingo‐Salvany and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Rosa Lamarca

54 papers receiving 2.7k citations

Hit Papers

Inhaled Combined Budesonide–Formoterol as Needed in Mild ... 2018 2026 2020 2023 2018 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
    2018 366 citations Paul M. O’Byrne, J. Mark FitzGerald et al. profile →
  2. As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
    2018 303 citations Eric D. Bateman, Helen K. Reddel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosa Lamarca Spain 23 1.5k 1.4k 341 231 221 57 2.8k
Thomy Tonia Switzerland 29 2.1k 1.4× 1.1k 0.8× 322 0.9× 309 1.3× 268 1.2× 50 4.3k
Hatice S. Zahran United States 19 774 0.5× 1.3k 1.0× 550 1.6× 219 0.9× 210 1.0× 30 2.7k
Julia AE Walters Australia 35 1.8k 1.1× 913 0.7× 431 1.3× 116 0.5× 505 2.3× 64 2.9k
L. Keoki Williams United States 30 962 0.6× 1.4k 1.0× 351 1.0× 88 0.4× 353 1.6× 93 3.6k
Martyn R Partridge United Kingdom 35 2.3k 1.5× 1.9k 1.4× 909 2.7× 72 0.3× 336 1.5× 134 3.8k
Dorothy Wakefield United States 31 624 0.4× 674 0.5× 430 1.3× 81 0.4× 337 1.5× 124 2.6k
Laura Q. Rogers United States 40 731 0.5× 1.4k 1.0× 611 1.8× 75 0.3× 173 0.8× 139 4.7k
Michelle M. Cloutier United States 36 2.1k 1.4× 2.3k 1.7× 774 2.3× 58 0.3× 240 1.1× 114 4.4k
F Gutzwiller Switzerland 29 563 0.4× 358 0.3× 358 1.0× 243 1.1× 269 1.2× 165 2.5k
Catherine R. Messina United States 30 931 0.6× 469 0.3× 285 0.8× 138 0.6× 207 0.9× 97 3.0k

Countries citing papers authored by Rosa Lamarca

Since Specialization
Citations

This map shows the geographic impact of Rosa Lamarca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Lamarca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Lamarca more than expected).

Fields of papers citing papers by Rosa Lamarca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Lamarca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Lamarca. The network helps show where Rosa Lamarca may publish in the future.

Co-authorship network of co-authors of Rosa Lamarca

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Lamarca. A scholar is included among the top collaborators of Rosa Lamarca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Lamarca. Rosa Lamarca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reddel, Helen K., Guy Brusselle, Rosa Lamarca, et al.. (2023). Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy. The Journal of Allergy and Clinical Immunology In Practice. 11(7). 2104–2114.e3. 2 indexed citations
3.
4.
Reddel, Helen K., Paul M. O’Byrne, J. Mark FitzGerald, et al.. (2021). Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma. The Journal of Allergy and Clinical Immunology In Practice. 9(8). 3069–3077.e6. 18 indexed citations
5.
Ferguson, Gary T., Tor Skärby, Lars H. Nordenmark, et al.. (2020). <p>Unreported and Overlooked: A Post Hoc Analysis of COPD Symptom-Related Attacks from the RISE Study</p>. International Journal of COPD. Volume 15. 3123–3134. 3 indexed citations
6.
Pearlman, David S., Julie McLaren, Rosa Lamarca, et al.. (2017). Efficacy and safety of budesonide/formoterol pMDI vs budesonide pMDI in asthmatic children (6–<12 years). Annals of Allergy Asthma & Immunology. 118(4). 489–499.e1. 12 indexed citations
7.
Jones, Paul, Dave Singh, Eric Bateman, et al.. (2012). Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. European Respiratory Journal. 40(4). 830–836. 141 indexed citations
8.
Singh, David, Eric Bateman, Paul Jones, et al.. (2011). The ATTAIN study: Bronchodilatory effect of aclidinium bromide in chronic obstructive pulmonary disease (COPD). European Respiratory Journal. 38(Suppl 55). p875–p875. 1 indexed citations
9.
Agustí, Àlvar, Paul Jones, Eric Bateman, et al.. (2011). Improvement in symptoms and rescue medication use with aclidinium bromide in patients with chronic obstructive pulmonary disease: Results from ATTAIN. European Respiratory Journal. 38(Suppl 55). p874–p874. 5 indexed citations
10.
Jones, Paul, Stephen I. Rennard, Àlvar Agustí, et al.. (2011). Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease. Respiratory Research. 12(1). 55–55. 70 indexed citations
11.
Chanez, Pascal, Peter Burge, Rasmus Holmboe Dahl, et al.. (2009). Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Pulmonary Pharmacology & Therapeutics. 23(1). 15–21. 41 indexed citations
12.
Joos, Guy, Vanessa Schelfhout, Ruben Pauwels, et al.. (2009). Bronchodilatory effects of aclidinium bromide, a long-acting muscarinic antagonist, in COPD patients. Respiratory Medicine. 104(6). 865–872. 27 indexed citations
13.
Newman, Stephen P., et al.. (2009). Lung Deposition of Aclidinium Bromide from Genuair®, a Multidose Dry Powder Inhaler. Respiration. 78(3). 322–328. 43 indexed citations
14.
Orfila, Francesc, Montse Ferrer, Rosa Lamarca, et al.. (2006). Gender differences in health-related quality of life among the elderly: The role of objective functional capacity and chronic conditions. Social Science & Medicine. 63(9). 2367–2380. 233 indexed citations
15.
Prieto, Luis, Jordi Alonso, & Rosa Lamarca. (2003). Classical Test Theory versus Rasch analysis for quality of life questionnaire reduction.. Health and Quality of Life Outcomes. 1(1). 27–27. 210 indexed citations
16.
Domingo‐Salvany, Antònia, Rosa Lamarca, Montse Ferrer, et al.. (2002). Health-related Quality of Life and Mortality in Male Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 166(5). 680–685. 338 indexed citations
17.
Miravitlles, Marc, Alvarez-Sala Jl, Rosa Lamarca, et al.. (2002). Treatment and quality of life in patients with chronic obstructive pulmonary disease. Quality of Life Research. 11(4). 329–338. 43 indexed citations
18.
Lamarca, Rosa, et al.. (2001). Performance of a perceived health measure in different groups of the population. Journal of Clinical Epidemiology. 54(2). 127–135. 13 indexed citations
19.
Orfila, Francesc, Montse Ferrer, Rosa Lamarca, & Jordi Alonso. (2000). Evolution of self-rated health status in the elderly. Journal of Clinical Epidemiology. 53(6). 563–570. 43 indexed citations
20.
Sunyer, Jordi, Rosa Lamarca, & Jordi Alonso. (1998). Smoking after Age 65 Years and Mortality in Barcelona, Spain. American Journal of Epidemiology. 148(6). 575–580. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomy Tonia Breakdown of academic impact, for papers by Hatice S. Zahran Breakdown of academic impact, for papers by Julia AE Walters Breakdown of academic impact, for papers by L. Keoki Williams Breakdown of academic impact, for papers by Martyn R Partridge Breakdown of academic impact, for papers by Dorothy Wakefield Breakdown of academic impact, for papers by Laura Q. Rogers Breakdown of academic impact, for papers by Michelle M. Cloutier Breakdown of academic impact, for papers by F Gutzwiller Breakdown of academic impact, for papers by Catherine R. Messina
Rankless by CCL
2026